logo

I-Mab (IMAB)



Trade IMAB now with
  Date
  Headline
8/4/2020 8:19:09 AM China Accepts IND Application For Eftansomatropin Pivotal Trial In Pediatric Patients With Growth Hormone Deficiency
5/21/2020 8:16:02 AM I-Mab And Genexine: China NMPA Clears Initiation Of Phase 2 Clinical Trial Of TJ107/HyLeukin-7
5/20/2020 4:05:44 AM I-Mab Announces Opening Of Its Hong Kong Office
5/13/2020 8:04:42 AM I-Mab Says First Patient Dosed With CD73 Antibody TJD5 In Phase 1/2 Clinical Trial In China For Advanced Solid Tumors
4/2/2020 8:26:15 AM I-Mab Announces First Patient Dosed In Phase 1/2a Clinical Trial Of TJC4 In China In Patients With R/r AML
3/31/2020 7:15:33 AM I-Mab FY Loss Per Share RMB201.2/$28.9;non-GAAP Adj Loss Per Share RMB131.4/$18.9
3/23/2020 7:39:56 AM I-Mab Appoints Gigi Feng As VP And Global Head Of Corporate Communications
1/17/2020 1:11:20 AM I-Mab Prices IPO Of 7.41 Mln ADSs At $14/Shr